Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1993/001409external-prioritypatent/WO1994007883A1/ja
Application filed by Tsumura & CofiledCriticalTsumura & Co
Publication of NO942013D0publicationCriticalpatent/NO942013D0/no
Publication of NO942013LpublicationCriticalpatent/NO942013L/no
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Lltiumsalt av 2-0-oktadecylascorbinsyre er nyttig som en farmasøytisk sammensetning for å hindre eller behandle en funksjonell forstyrrelse l slrkulasjons- systemet.
NO942013A1992-10-021994-05-31Litiumsalt av 2-0-alkylaskorbinsyre
NO942013L
(no)
Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.